PMID: 9445199Jan 28, 1998Paper

A prospective crossover randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with interleukin-2

Cancer
I RaadS Legha

Abstract

The aim of this study was to determine the efficacy of novobiocin and rifampin as oral antibiotic prophylaxis for the prevention of catheter-related infection in melanoma patients treated with interleukin-2 (IL-2) plus interferon-alpha and chemotherapy (biochemotherapy). Patients with advanced melanoma who were treated with biochemotherapy at the University of Texas M. D. Anderson Cancer Center were randomized in a crossover study to receive either oral antibiotic prophylaxis consisting of novobiocin and rifampin or observation alone over a 35-day course period. Patients were subsequently "crossed over" to the opposite arm of the study for an additional 35-day period, with each serving as his or her own control. Twenty-six patients were enrolled. Nine patients (35%) failed to tolerate oral antibiotics because of severe nausea and vomiting; 17 patients (65%) were crossed over and considered evaluable. During the control patient courses, 71% of evaluable patients had infectious complications, 41% had a catheter-associated bacteremia, and 53% had a local catheter infection. In contrast, of the patients treated with antibiotic prophylaxis, only 12% had an infectious complication (P = 0.001), 12% had a local catheter infection (P = ...Continue Reading

References

Jun 9, 1977·The New England Journal of Medicine·D G MakiH W Sarafin
Aug 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M RichardsP Skosey
Mar 15, 1991·Cancer·J M RichardsN J Vogelzang
Apr 5, 1990·The New England Journal of Medicine·M S KlempnerM B Atkins
Oct 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C OrceseC Besana
Jan 1, 1990·The Journal of Infectious Diseases·B F FarberA G Clogston
Jan 15, 1990·Annals of Internal Medicine·D R SnydmanM B Atkins
Jan 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S N BockP A Pizzo
Aug 1, 1987·The Journal of Antimicrobial Chemotherapy·R A ProctorG Brandt
Apr 1, 1985·The Journal of Antimicrobial Chemotherapy·T J WalshH C Standiford
Jan 1, 1985·Infection·B Sugarman, L R Epps
Jun 1, 1984·The Journal of Antimicrobial Chemotherapy·S DixsonJ M Hamilton-Miller
Mar 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·I I RaadG P Bodey
Feb 1, 1995·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·UNKNOWN Hospital Infection Control Practices Advisory Committee (HICPAC)
Dec 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A S GuleriaJ H Einhorn
Nov 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D KhayatR Franks
Jan 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B A PockajS A Rosenberg
Feb 1, 1996·The Journal of Infectious Diseases·I RaadG P Bodey
Nov 1, 1995·Antimicrobial Agents and Chemotherapy·I RaadG P Bodey

❮ Previous
Next ❯

Citations

Dec 10, 2013·Chemical Reviews·Claudine Mayer, Yves L Janin
Apr 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Naomi P O'GradyUNKNOWN Healthcare Infection Control Practices Advisory Committee (HICPAC)
May 5, 2005·Applied and Environmental Microbiology·Alessandra S EustáquioLutz Heide
Mar 19, 2008·Antimicrobial Agents and Chemotherapy·Christine AnderleLutz Heide
Mar 10, 2010·Antimicrobial Agents and Chemotherapy·Steven A RogersChristian Melander
Jun 1, 1999·The Journal of Antimicrobial Chemotherapy·T S Elliott
Mar 21, 2003·The New England Journal of Medicine·David C McGee, Michael K Gould
Apr 29, 2011·American Journal of Infection Control·Naomi P O'GradyUNKNOWN Healthcare Infection Control Practices Advisory Committee
Nov 2, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J Carratalà
Aug 27, 2011·Analytical Biochemistry·Niranjan Parajuli, Gavin J Williams
Dec 17, 2009·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·R F ChemalyI I Raad
Dec 17, 2014·International Journal of Oncology·Zuzana SolárováPeter Solár
Apr 20, 2001·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·I RaadG Mansour
Jan 1, 2004·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Juan Alonso-EchanoveRobert P Gaynes
Mar 6, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles A SchifferMark Levine
Aug 26, 2006·Cardiovascular and Interventional Radiology·Arul GaneshanRaman Uberoi
Sep 1, 2007·Current Opinion in Critical Care·Matthew E Falagas, Petros Kopterides
Nov 28, 2013·The Cochrane Database of Systematic Reviews·Marianne D van de WeteringTheresa A Lawrie
Aug 10, 1999·The Pediatric Infectious Disease Journal·A M Loeffler
Apr 24, 2014·Organic & Biomolecular Chemistry·Ram Tilak NaganaboinaRama Krishna Peddinti
Apr 14, 2010·Journal of Natural Products·Sarot CheenprachaLeng Chee Chang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.